Seeking Alpha

Medicis (MRX) receives a notice of allowance from the U.S. Patent and Trademark Office for...

Medicis (MRX) receives a notice of allowance from the U.S. Patent and Trademark Office for Zyclara Cream, for the treatment of actinic keratosis.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector